The present invention relates to a serine threonine kinase. The invention also relates to nucleic acids encoding the kinase, vectors, host cells, antibodies and recombinant methods for producing the h2520-59 polypeptide. In addition, the invention discloses therapeutic, diagnostic and research utilities for h2520-59 and related products.

 
Web www.patentalert.com

< Method and apparatus for normalizing and converting structured content

< Radiolabeled neuropeptide Y Y5 receptor antagonists

> Bioresorbable stent

> Method and apparatus for establishing context among events and optimizing implanted medical device performance
~ 00254